TruaceTracing the truth around AIWednesday, August 5, 2026
TRV-2026-0564Version 1 · Certified

Written 2026-07-25 06:09:55 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0564
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-07-25T06:09:55.149599Z
status: published
lens: trace
sector: health
headline: Ultra-widefield color fundus images and artificial intelligence for diagnosis of diabetic retinopathy: A systematic review and meta-analysis
dek: Ultra-widefield (UWF) fundus cameras capture a larger retinal area without pupil dilation. We summarized evidence and diagnostic performance of artificial intelligence (AI)-driven diabetic retinopathy (DR) assessments using UWF images (UWFIs). We searched PubMed, Scopus, the Cochrane Library, and Web of Science to February 9, 2025, for studies evaluating DR using UWFIs and AI analyses. We followed the PRISMA guidelines and assessed study quality using the Joanna Briggs Institute Critical Appraisal Checklist for…
gain_title: AI-driven diabetic retinopathy screening using ultra-widefield fundus images achieved a summary sensitivity of 85.0% and AUC of 0.870 in meta-analysis.
problem_title: AI-driven diabetic retinopathy screening using ultra-widefield fundus images showed limited specificity of 72.5% in meta-analysis.
trace_subject: AI-driven diabetic retinopathy screening using ultra-widefield fundus images
gain_reading: AI-driven diabetic retinopathy screening using ultra-widefield fundus images achieved a summary sensitivity of 85.0% and AUC of 0.870 in meta-analysis.
gain_evidence: summary sensitivity, specificity, and area under receiver operating characteristic curve for AI-driven DR screening using UWFI were 85.0%, 72.5%, and 0.870 (0.838-0.897), respectively | UWFI-based AI screening showed acceptable sensitivity but limited specificity
problem_reading: AI-driven diabetic retinopathy screening using ultra-widefield fundus images showed limited specificity of 72.5% in meta-analysis.
problem_evidence: UWFI-based AI screening showed acceptable sensitivity but limited specificity | summary sensitivity, specificity, and area under receiver operating characteristic curve for AI-driven DR screening using UWFI were 85.0%, 72.5%, and 0.870
quick_read: A systematic review and meta-analysis to February 9, 2025, evaluated artificial intelligence for diabetic retinopathy assessment using ultra-widefield color fundus images, which capture a larger retinal area without pupil dilation. Of 527 records, 17 studies were reviewed and four were meta-analyzed, all using Optos software, to estimate sensitivity and specificity for AI-driven screening.

The pooled performance suggests AI can detect diabetic retinopathy from ultra-widefield images with acceptable sensitivity but lower specificity, indicating potential for screening but risk of false positives. Uncertainty remains because the evidence base is small and lacks rigorous external validation across diverse datasets and ultra-widefield platforms, limiting generalizability to broader clinical use.
limitation: Findings are limited by small evidence base and lack of diverse external validation across platforms.
tag: Automated dual reading
key_points: Systematic review searched PubMed, Scopus, Cochrane Library, and Web of Science to February 9, 2025, identifying 527 records with 17 included in review and four in meta-analysis. | All included studies used Optos software for ultra-widefield imaging. | Included studies covered DR discrimination from multiple disorders, stage classification, screening, referable pathology detection, progression prediction, and clinical feature detection.
rundown: The review included 17 studies in the systematic review and four studies in the meta-analysis, all using Optos software, with study quality assessed using the Joanna Briggs Institute Critical Appraisal Checklist for diagnostic accuracy.

Study purposes varied: two evaluated DR discrimination from multiple retinal disorders, six addressed DR stage classification based on guideline scales, six evaluated DR screening, and one each focused on referable pathology detection, progression prediction, and clinical feature detection.
sources:
- peer_reviewed | Retina | https://doi.org/10.1097/iae.0000000000004939 | 2026-07-24
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
957677c8385dbd935eacaa8aefd69eb9082b1257c0060243e5b91aabb69537f7
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0564 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.